US government joins Natrecor whistleblower suits
This article was originally published in Scrip
Executive Summary
The US government has joined two whistleblower suits filed against Johnson & Johnson and its Scios unit, alleging that the companies marketed the heart drug Natrecor (nesiritide) for an unapproved use, according to the Department of Justice.